bramah-n-singh documents

Significance and Control of Cardiac Arrhythmias in Patients with Congestive Cardiac Failure
Documents Significance and Control of Cardiac Arrhythmias in Patients with Congestive Cardiac Failure
Use of calcium antagonists for cardiac arrhythmias
Documents Use of calcium antagonists for cardiac arrhythmias
Hemodynamic and electrocardiographic correlates of symptomatic and silent myocardial ischemia: Pathophysiologic and therapeutic implications
Documents Hemodynamic and electrocardiographic correlates of symptomatic and silent myocardial ischemia: Pathophysiologic and therapeutic implications
Introduction
Documents Introduction
When is QT prolongation antiarrhythmic and when is it proarrhythmic?
Documents When is QT prolongation antiarrhythmic and when is it proarrhythmic?
Historical development of the concept of controlling cardiac arrhythmias by lengthening repolarization: Particular reference to sotalol
Documents Historical development of the concept of controlling cardiac arrhythmias by lengthening repolarization: Particular reference to sotalol
Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction
Documents Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction
Expanding clinical role of unique class III antiarrhythmic effects of sotalol
Documents Expanding clinical role of unique class III antiarrhythmic effects of sotalol
Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem
Documents Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem
Bepridil therapy: Guidelines for patient selection and monitoring of therapy
Documents Bepridil therapy: Guidelines for patient selection and monitoring of therapy
Safety profile of bepridil determined from clinical trials in chronic stable angina in the United States
Documents Safety profile of bepridil determined from clinical trials in chronic stable angina in the United States
Controlling cardiac arrhythmias by lengthening repolarization: Historical overview
Documents Controlling cardiac arrhythmias by lengthening repolarization: Historical overview
Introduction
Documents Introduction
Introduction
Documents Introduction
Implantable cardioverter-defibrillators: Not the ultimate gold standard for gauging therapy of VT/fibrillation
Documents Implantable cardioverter-defibrillators: Not the ultimate gold standard for gauging therapy of VT/fibrillation
Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents
Documents Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents
Choice and chance in drug therapy of cardiac arrhythmias: Technique versus drug-specific responses in evaluation of efficacy
Documents Choice and chance in drug therapy of cardiac arrhythmias: Technique versus drug-specific responses in evaluation of efficacy
Electrophysiologic and hemodynamic effects of slow-channel blocking drugs
Documents Electrophysiologic and hemodynamic effects of slow-channel blocking drugs
New perspectives in the pharmacologic therapy of cardiac arrhythmias
Documents New perspectives in the pharmacologic therapy of cardiac arrhythmias
The historical development, cellular electrophysiology and pharmacology of amiodarone
Documents The historical development, cellular electrophysiology and pharmacology of amiodarone
Introduction:: A New Age in the Pharmacologic Therapy of Cardiac Arrhythmias
Documents Introduction:: A New Age in the Pharmacologic Therapy of Cardiac Arrhythmias